Erythropoietin enhances immune responses in mice. (Q51987962)

19 April 2018

title

Erythropoietin enhances immune responses in mice. (English)

1 reference

19 April 2018

1 reference

Odelia Katz

1

1 reference

19 April 2018

Lidor Gil

2

1 reference

19 April 2018

Lilach Lifshitz

3

1 reference

19 April 2018

Sara Prutchi-Sagiv

4

1 reference

19 April 2018

Max Gassmann

5

1 reference

19 April 2018

Moshe Mittelman

6

1 reference

19 April 2018

Drorit Neumann

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

37

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

1584-1593

1 reference

19 April 2018

The pleiotropic effects of erythropoietin in the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

Effects of erythropoietin on brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Non-erythroid functions of erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

The polymorphonuclear leukocyte--a new target for erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin receptor mRNA expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin and VEGF exhibit equal angiogenic potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Emerging biological roles for erythropoietin in the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

The brain erythropoietin system and its potential for therapeutic exploitation in brain disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Effect of recombinant human erythropoietin on human IgE production in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Improved immunoglobulin production in dialysis patients treated with recombinant erythropoietin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Regulation of immunoglobulin isotype expression in mice by antibodies in immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Short-term effect of erythropoietin on T-cell mitogenic proliferation in chronic renal failure patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

The Influence of Recombinant Human Erythropoietin on Tumor Necrosis Factor alpha and Interleukin-10 Production by Whole Blood Cell Cultures in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

The effect of uremia and transplantation on lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Causes of Death in Patients Receiving Long-Term Hemodialysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Immune system dysregulation in uremia: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin enhances immunoglobulin production and proliferation by human plasma cells in a serum-free medium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin may impair, not improve, cancer survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Homing of the myeloma cell clone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637025

7 January 2021

Identifiers

DOI

10.1002/EJI.200637025

1 reference

19 April 2018

release_jsd4cmzudbf53mtspf4fz5v4am

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jsd4cmzudbf53mtspf4fz5v4am

24 November 2022

mapped directly with Wikidata item

1 reference

19 April 2018